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ABSTRACT

Background: Gestational diabetes mellitus (GDM) is a prevalent and growing epidemic
that affected 8.2% of births in 2016 in the United States. Previous studies have shown
that low magnesium (Mg) is associated with type II diabetes (T2DM), and the
pathophysiology of GDM and T2DM is similar.
Objective: To determine if low total Mg intake is associated with the risk of having
GDM.
Design: We did a cross-sectional secondary data analysis using data from the 2005-2007
Infant Feeding Practices Study II which used a validated diet history questionnaire to
collect dietary data. We analyzed total Mg intake from 1217 pregnant women in their
third trimester and ran unadjusted and adjusted logistic regression models. Adjusted
models included age, pre-pregnancy BMI, family history of T2DM, energy intake from
food, and smoking as covariates.
Results: Mean total Mg intake was 332+138mg/day and 8.8% of women consumed a
dietary supplement containing Mg. In the unadjusted model, risk of GDM was not higher
with low total Mg intake (OR [95% CI]: 0.96 [0.61, 1.51]). Adjusting for all covariates
did not change the association (1.06 [0.64, 1.76]).
Conclusions: Total Mg intake was not significantly associated with a higher risk of
developing GDM. While this study found no association, a study with a larger sample
size and adequate power, using dietary intake to measure total Mg status may indicate
more significant findings.
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Introduction
The prevalence of gestational diabetes mellitus (GDM) in the United States (US)
reached 8.2% in 2016 (1) and globally impacts about 14% (18 million) of births each year
(2–5). In the US in 2007, GDM-related health concerns cost an additional $3,305 per
pregnancy, totaling $636 million in increased healthcare dollars (6). Gestational diabetes
is traditionally identified between 24-28 weeks of gestation and is defined as a fasting
blood glucose of >126 mg/dL or a 2 hour post prandial 75g oral glucose tolerance test
(OGTT) value of over 200 mg/dL (2,7). Gestational diabetes can lead to adverse maternal
and child health outcomes including increased risks at birth (e.g. high infant birthweight,
macrosomia [a newborn with a birthweight >4000g larger than average], shoulder
dystocia [when the neonate’s shoulders are stuck in the mother’s pelvis], cesarean section
[c-section], and stillbirth) and increased risk for the child and mother to develop chronic
diseases later in life (e.g. type II diabetes mellitus [T2DM], cardiovascular disease, and
obesity) (3,4).
Gestational diabetes and T2DM are diagnosed via the same tests and criteria, as
the pathophysiology of the two are similar (8–10). Gestational diabetes and T2DM occur
when the pancreas still synthesizes insulin but the insulin is not effective, which is known
as insulin resistance (8,9). Research shows low Mg intake is related to the prevalence of
T2DM due to its role in the secretion of insulin and activation of the insulin receptor,
which initiates a cascade for glucose uptake by cells (11–14). A randomized control trial
by Asemi et al. (15) supplemented Mg for women with GDM which led to improved
metabolic outcomes including decreased insulin and fasted plasma glucose (15). Like
many other studies (14,16–19), Asemi et al. (15) used serum Mg to identify blood Mg
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concentrations and assess Mg status. However, using serum Mg as a biomarker is a poor
indicator for Mg total body status and dietary intake, as overall body Mg can be low
without it being reflected in the serum (20). Therefore, it is important to target total Mg
intake, as no current research to our knowledge uses low total Mg intake (which includes
dietary Mg intake and Mg intake from dietary supplements) as their indicator for Mg
status while assessing the risk of having GDM (2,10,17,18). While there is sufficient
evidence to support the relationship between low Mg and T2DM, more research needs to
be done to explore the effects of low total Mg intake and GDM.
This retrospective, cross-sectional, secondary data analysis uses the Infant
Feeding Practices Study II (IFPS II) from 2005-2007 to identify whether a relationship
between Mg intake and GDM exists. This research uses results from a dietary history
questionnaire (DHQ) used in IFPS II study taken during the mothers’ third trimester.

Methods
Study Design
We conducted a cross-sectional, secondary-data analysis using 2005-2007 IFPS II
data collected by the Food and Drug Administration (FDA) and the Centers for Disease
Control and Prevention (CDC) which was Institutional Review Board approved by
the FDA’s Research Involving Human Subjects Committee and the US Office of
Management and Budget (21,22). This study analyzed whether total Mg intake was
significantly associated with self-reported GDM. We hypothesized low total Mg intake (<
the recommended dietary allowance (RDA) during pregnancy, which is a 400mg/day for
women 18 years old, 350mg/day for women 19-30 years old, and 360mg/day for women
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over 30 years old (23)) would be significantly associated with a higher risk of selfreported GDM (11).
Study Population
The IFPS II was a longitudinal study for which pregnant women were recruited
and postnatal follow-up on the mother and child continued until the child was 6 years old
(22). Participants were recruited from a nationally distributed consumer opinion panel of
500,000 US households (22). In a survey that is annually collected from this consumer
opinion panel, women who were pregnant with a singleton between the ages of 18-40
years old were identified and sent prenatal questionnaires, of which 4902 responded
(must reside in zip codes unaffected by the Gulf Coast hurricanes of 2005) (22). From
this cohort, 1749 were 28-32 weeks gestation and were sent a modified Dietary History
Questionnaire (DHQ) during May-August 2005, of which 1444 women completed and
returned before their infants were born (Figure 1) (22). The DHQ was modified from a
validated quantitative food frequency questionnaire developed by the National Cancer
Institute to better suit a pregnant population (modifications include recall period as 1
month instead of 1 year and questions were added about fish intake and dietary
supplements) and included 149 questions (21,22). A more detailed explanation of the data
collection methods can be found in a descriptive study by Fein et al. 2008 (22).
Statistical Analysis
Daily dietary Mg intake was calculated from the DHQ using Diet*Calc software,
which estimates nutrient intake from the DHQ (24). Gestational diabetes was established
in the prenatal survey in which participants answered “yes”, “no”, or “don’t know/not
sure” to the question, “Have you had gestational diabetes with this pregnancy?” Those
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who replied “don’t know/not sure” (n=141) to the question were excluded for analysis
(Figure 1).
Statistical Analysis System (SAS) 9.4 software (SAS 9.4, Cary, NC) was used for
all statistical analyses.
Logistic regression analysis was used to determine whether the risk of GDM
prevalence differed between high (> RDA per age group) and low (< RDA per age group)
total Mg intake. The statistically significant level was set at p≤0.05.
Potential confounding variables were identified in the literature, and included age,
education, pre-pregnancy body mass index (BMI), and family history of diabetes (25–
31). Age was included as older women are at a higher risk of developing GDM and
decreased Mg intake (25,26). Education was considered as a confounding variable as less
education is a risk factor for GDM and tend to have lower Mg intake (26,27). High prepregnancy BMI and family history of diabetes are risk factors for GDM (4,28).
Additionally, a high pre-pregnancy BMI and low Mg intake are inversely associated with
overweight and obese pre-pregnancy (28,31,32). If potential confounding variables were
significantly associated with risk of having GDM (p<0.05), then they were included in
the adjusted model. Of these potential confounding variables, age, pre-pregnancy BMI (4
categories), and family history of T2DM were included as covariates for adjusted model
1. Adjusted model 2 also controlled for age and family history of T2DM, but here we
dichotomized pre-pregnancy BMI (underweight/normal BMI <25 kg/m2 and
overweight/obese BMI >25 kg/m2), and included energy intake from food (residuals), and
smoking.
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Continuous variables (age and BMI) were examined for normality using a
Kruskal Wallis test (p<0.05). Data distributions were examined for outliers outside of +/3 standard deviations from the mean (n=18) (Figure 1).
Effect size for high and low total Mg intake was calculated using this equation
below (33).

With our sample of n=1217, we determined power at 0.107 and an effect size of 0.02
using G*power 3.0 and the results from this equation (34).

Results
Of the 1749 women who were in their third trimester, 305 women were removed
if they had a previous diagnosis of diabetes resulting in 1376 participants. Women who
responded “don’t know/not sure” to the question “have you been diagnosed with GDM
during this pregnancy?” (n=141), and if their total Mg intake was +/- 3 standard
deviations from the media (n=18) were also excluded from this analysis, resulting in a
total of 1217 women for this study (Figure 1). The average age of the women in this
study cohort was 29.5+5.5 years old with the majority having some college education
(36.9% some college, 37.2% college graduate). Of respondents, about 34.3% had a
family history of T2DM and 45.2% reported normal pre-pregnancy BMI between 18.524.9kg/m2, and 47.7% had a BMI over 25.0kg/m2 (23.3% overweight, 24.1% obese). The
mean total Mg intake was 332+138mg/day. There was no statistical significance for the
risk of developing GDM between the 25th percentile of total Mg intake at 230mg/day, and
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the 75th percentile at 406mg/day (p=0.18). Dietary supplements were used by 8.8% of
participants and the mean total Mg intake for participants who reported dietary
supplement intake was 344+143mg/day, while those who did not consume a dietary
supplement had a mean Mg intake of 331+137mg/day. In total, 7.2% of participants
responded “yes” when asked if they have been diagnosed with GDM during this
pregnancy.
For the logistic regression, we identified total Mg intake as high (> RDA per age
group) or low (< RDA per age group). Risk of having GDM was not significantly
associated with low Mg intake in the unadjusted and adjusted models. In the unadjusted
model, risk of having GDM was not higher with low total Mg intake (OR [95% CI]: 0.96
[0.61, 1.51]), dietary intake (1.00 [0.62, 1.62]), or for those who did use dietary
supplements (0.75 [0.21, 2.64]). Adjusted model 1 for covariates did not change the
association for total Mg intake (0.97 [0.59,1.58]), dietary Mg intake (0.95 [0.56, 1.59]),
or use of dietary supplements (1.22 [0.27, 5.41]) and risk of having GDM (Table 2).
Adjusted model 2 also had minimal effect for total Mg intake (1.06 [0.64, 1.76]), dietary
Mg intake (1.03 [0.60, 1.75]), or use of dietary supplements (1.13 [0.23, 5.25]) and risk
of having GDM (Table 2). Adjusted model 1 controlled for the covariates age, family
history of T2DM, and pre-pregnancy BMI (4 categories), all of which were still
significantly associated with risk of having GDM. Adjusted model 2 also controlled for
age and family history of T2DM, but here we dichotomized pre-pregnancy BMI and
included energy intake from food (residuals), and smoking. Energy intake from food was
significantly associated with Mg intake (r2=0.85), and smoking (0.45 [0.23, 0.84]) and
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dichotomized BMI (0.40 [0.24, 0.67]) were significantly associated with risk of having
GDM.

Discussion
In this secondary analysis of IFPS II study, total Mg intake was not significantly
associated with the risk of having self-reported GDM for the adjusted and unadjusted
models. The average total Mg intake was slightly below the recommended daily
allowance (23) with a small percentage who consumed a dietary supplement. Differences
in age, family history of T2DM, and pre-pregnancy BMI were considered significant, and
used as covariates in the adjusted model.
Several studies have analyzed whether there is a relationship between Mg and
GDM prevalence. When comparing other studies to our research sample characteristics
were similar, however, these studies used different methods for diagnosing high and low
Mg and GDM. One study by Tasdemir et al. (35) looked at ionized and total body Mg
with a smaller dataset (n=85) in non-GDM compared to GDM participants. They found
low ionized Mg in patients with GDM, which helped lead us to our hypothesis that low
Mg intake would be associated with GDM. However, our results did not show a
significant association like Tasdemir et al. (35) which could be because ionized levels of
Mg may not directly reflect Mg intake, whereas measuring dietary Mg does. The mean
age between non GDM (26.8+6.6) and GDM groups (30.8+6) were similar to ours
(28.9+5.5 and 31+5.4, respectively) and like our sample, age was statistically significant
for reported GDM (35). Those in the GDM group also had a similar percentage for family
history of T2DM (47.5%) as our study (52.9%) and were significantly associated with
GDM (35).
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Another group of researchers (15) investigated Mg supplementation on metabolic
status and its effect on pregnancy outcomes. This study also used a smaller sample size
(n=70) compared to ours (n=1217) with a similar mean age of 29.3+3.9 (15). The results
showed Mg supplementation was associated with decreased serum insulin and fasting
plasma glucose, but like our results, did not find any direct association with GDM (15).
A randomized control trial conducted by Zarean and Tarjan 2017 (36) used a
sample of 180 pregnant women and compared 3 groups of 60 participants with Mg
supplementation (group 1: control group with serum Mg >1.9 mg/dL; group 2: serum Mg
levels <1.9 mg/dL and given a multimineral tablet; group 3: serum Mg levels <1.9 mg/dL
given a Mg supplement). This study also used serum Mg as its Mg status marker. The
results showed those who received a Mg supplement were less likely to develop GDM,
which is inconsistent with our results. These results could be different from ours as serum
Mg is not a valid marker of total Mg intake (20).
The physiological mechanism of insulin resistance between T2DM and GDM is
similar, and low Mg intake has shown to impact development of T2DM (4). The studies
that investigated low serum Mg and GDM prevalence showed an inverse relationship
between the two variables, while supplementing with Mg decreased GDM prevalence
(15,35,36). However, our results did not show a significant association between low total
Mg intake and risk of having GDM.
Our findings may have differed from previous research for a number of reasons.
First being the risk of having GDM in the IFPS II dataset was self-reported, and therefore
likely under-reported. A study done in New Zealand by Lawrence et al.(37) found one
third of medically diagnosed GDM went unreported in a questionnaire. Additionally, our
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study used Mg intake from a DHQ, while these studies used serum Mg or experimented
with the effect of Mg supplements on GDM outcomes. Though there were other studies
that also did not have significant findings (30,38), there were none that specifically
analyzed total Mg intake compared to risk of having GDM in the US.
Our study has strengths and limitations that are worth reporting. The sample size
is considered large (n=1217) when compared to other studies (15,35,36). However, we
were unable to determine significant association between total Mg intake and risk of
having GDM, which could be due to having low power. Our power was likely low
because of the low amount of GDM diagnoses in this cohort (n=87, 7.2%). In order to
increase power to 80%, we would need a sample size n=19,623 for an effect size of 0.08
which would allow for a larger cohort with reported GDM. The DHQ used by IFPS II
was derived from the NCI by the FDA and CDC and was previously validated (22). A
limitation of this study is the cross-sectional design, as it does not allow for the
determination of a temporal relationship or causality between Mg intake and GDM onset.
Additionally, the DHQ did not differentiate whether the multivitamins or prenatal
vitamins the participants may be taking contained Mg, which could have affected total
and dietary supplemental intake. However, prenatal vitamins typically do not contain Mg
or if they do, they only contain about 150mg on average (about 40% of RDA during
pregnancy) (39,40). There is also a possibility that participants had undiagnosed preexisting type 1 or T2DM before this pregnancy, which could have interfered with the
validity of GDM diagnosis. Additionally, in the past there was not a standardized
diagnosis of GDM which could have an effect on true GDM diagnoses (4). It is also
possible there were some confounding variables that we did not recognize and are not
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adjusting for or were not included in the data. Though the study cohort collected in the
IFPS II dataset was nationally distributed, it may not represent the whole US population
(22). This is because the IFPS II data collection method used a self-selected consumer
panel and not a random sample due to the cost of recruiting women in their third
trimester, which may contribute to volunteer bias (22). Another limiting factor of this
study is the use self-reported data from the prenatal questionnaire and DHQ, which may
lead to response bias (22). However, DHQs are commonly used to asses total intake as
they are easy to administer, noninvasive, inexpensive and currently the best method to
measure Mg intake (41).
In conclusion, this secondary-data analysis revealed no significant association
between total Mg intake and GDM. Contrary to other markers of Mg status or studies
using interventions with Mg supplements, this research used dietary and dietary
supplement intake to determine if there was an association which is currently the most
accurate measure of Mg intake. Though it could not be proved with this study, it is still
possible there is an association between low Mg intake and risk of having GDM. The low
power for this sample may have contributed to the insignificant results, as only a small
fraction of women reported having GDM. With a larger sample size, 80% power could be
reached with an effect size of 0.08 so that significant differences could be detected if
present. This research was an important foundational step to further this investigation of
the relationship of total Mg intake and GDM, as it uses dietary intake to measure
micronutrient status in relation to incidence of disease which may give reason for further
exploration.
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Figures and Tables
Figure 1: Flow chart of inclusion criteria for women in the Infant Feeding Practices
Study II who provided diet history and GDM status used in this study.
n=500,000
Sample population
n=495,098 excluded:
Not pregnant in 3rd
trimester
n=4902
Pregnant respondents
in 3rd trimester &
returned prenatal
survey

n=3458 excluded:
Did not complete
DHQ

n=1444
n=209 excluded:
Reported diagnosis of
pre-existing diabetes
No response or “don’t
know/not sure” to
GDMa question
n=1235
n=18 excluded:
Removed outliers
+3 standard deviations
from median total Mgb
intake)
n=1217
Final sample included

aGestational

diabetes mellitus

bMagnesium
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Table 1: Maternal descriptive characteristics of the subsample population of 1217
women in the Infant Feeding Practices Study II who provided diet history and GDM
status.
Maternal Characteristic
Education*
High school or less
Some college
College graduate
No response
Age, years
Family history of
diabetesb
Type I*
Yes
No
No response
Type 2*
Yes
No
No response
Pre-pregnancy BMIc*
Underweightd
Normal weight
Overweight
Obese
No response
Mean total Mge intake
(mg/d)
Mean dietary Mg intake
(mg/d)
Mean Mg intake with Mg
supplement use (mg/d)
Mg supplement
Yes
No

Total
n=1217 (%)

Yes GDMa
n=87 (7.1%)

No GDM
n=1130 (92.9%)

229 (18.8%)
449 (36.9%)
453 (37.2%)
86 (7.1%)
28.9 + 5.5

16 (18.4%)
28 (32.2%)
37 (42.5%)
6 (6.9%)
31 + 5.4

213 (18.8%)
421 (37.3%)
416 (36.8%)
80 (7.1%)
28.8 + 5.4

55 (4.5%)
992 (81.5%)
170 (14.0%)

4 (4.6%)
68 (78.2%)
15 (17.2%)

51 (4.5%)
924 (81.8%)
155 (13.7%)

418 (34.3%)
678 (55.7%)
121 (10.0%)

46 (52.9%)
33 (37.9%)
8 (9.2%)

372 (32.9%)
645 (57.1%)
113 (10.0%)

67 (5.6%)
550 (45.2%)
288 (23.6%)
294 (24.1%)
18 (1.5%)

1 (1.2%)
25 (28.7%)
23 (26.4%)
36 (41.4%)
2 (2.3%)

66 (5.8%)
525 (46.5%)
265 (23.5%)
258 (22.8%)
16 (1.4%)

332 + 138

345 + 134

331 + 138

0.56

331 + 137

335 + 130

330 + 138

0.58

344 + 143

346 + 168

344 + 141

0.45

107 (8.8%)
1170 (96.1%)

11 (12.6%)
76 (87.4%)

96 (8.5%)
1034 (91.5%)

0.19

aGestational

P-value

0.53

0.0003

0.91

0.0001

0.0001

diabetes mellitus
bMaternal siblings, aunts/uncles, or parents
cBody Mass Index
dUnderweight <18.5 kg/m2, Normal weight = BMI 18.5-24.9 kg/m2, Overweight = BMI
25-29.9 kg/m2, Obese = BMI >30 kg/m2
eTotal maternal magnesium intake calculated from DHQ responses using Diet*Calc
software
*Missing data: education (n=131); type 1 diabetes (n=215); type 2 diabetes (n=166); BMI
(n=63)
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Table 2: Unadjusted and adjusted odds ratios (95% CI) from models examining
Mga intake status by GDMb prevalence from participants in the Infant Feeding
Practices Study II who completed the prenatal diet history questionnaire.
Mg intake
Total Mg intake
(n=1217)
< RDAe (n=766)
> RDA (n=451)
Dietary Mg intakeh
(n=1110)
< RDA (n=701)
> RDA (n=409)
Dietary supplement
(n=107)
< RDA (n=65)
> RDA (n=42)

Yes GDM
n=87 (7.2%)

Unadjusted
n=1217

Adjusted (1)c
n=1172

Adjusted (2)d
n=1072

54 (7.1%)
33 (7.3%)

0.96 (0.61, 1.51)
-

0.97 (0.59, 1.58)
-

1.06 (0.64, 1.76)
-

48 (6.9%)
28 (6.9%)

1.00 (0.62, 1.62)
-

0.95 (0.56, 1.59)
-

1.03 (0.60, 1.75)
-

6 (9.2%)
5 (11.9%)

0.75 (0.21, 2.64)
-

1.22 (0.27, 5.41)
-

1.13 (0.23, 5.25)
-

aMagnesium
bGestational

diabetes mellitus
cAdjusted for age, family history of type II diabetes, and pre-pregnancy BMI (<18.5
kg/m2, normal weight = BMI 18.5-24.9 kg/m2, overweight = BMI 25-29.9 kg/m2, obese =
BMI >30 kg/m2)
eTotal maternal magnesium intake calculated); missing n=138 due to no response from
covariates
dAdjusted for age, family history of type II diabetes, pre-pregnancy BMI (2 categories:
underweight/normal BMI <25 kg/m2 and overweight/obese BMI >25 kg/m2), energy
intake from food (residuals), and smoking; missing n=145 due to no response from
covariates
eRecommended daily allowance for Mg during pregnancy; 18 years old = 400 mg/day,
19-30 years old = 350 mg/day, and over 30 years old = 360 mg/day
hMissing data from those who consumed dietary supplement (n=107)
iMissing data from those who did not consume dietary supplement (n=1110)
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APPENDIX A: EXTENDED LITERATURE REVIEW
Chapter 1: Magnesium
Background, Functions, and Distribution
Magnesium is the fourth most abundant cation in our body, and an essential
mineral that has many physiological functions (18,42). It is a cofactor for over 600
enzymatic reactions, it activates over 200 enzymes, and is involved in processes like
protein synthesis, energy production, muscle function, blood glucose regulation, nerve
function, blood pressure, oxidative phosphorylation, and glycolysis (12,43). It was first
identified as an essential mineral in 1926 by J. Leroy, and in the 1950s clinical effects
from Mg deficiency were recognized, giving rise to the many roles requiring Mg (42). As
an essential mineral is defined as a mineral or nutrient that is necessary for our bodies but
cannot synthesize (44). When Mg is deficient, there can be detrimental effects including
muscular and neurological symptoms (including tetany, spasms, and tremoring), poor
appetite, nausea, and vomiting, so it is important we meet our required needs (11,45).
Serum Mg deficiency, or hypomagnesemia, is typically defined as serum Mg levels less
than 0.7-0.75 mmol/L, 1.4mEq/L, or 1.7 mg/dl and is prevalent among both developed
and developing countries (12,43,46). It is associated with hypocalcemia as well, and side
effects include weakness, fatigue, muscle cramping, tetany, feeling numb, and seizures
(46).
Physiology
Our bodies cannot physically store Mg, therefore we retain Mg to maintain
homeostasis based on physiological needs (47). Healthy adults typically have about 24g
of Mg in their body, which amounts to about 0.4g/kg, where about 60-65% resides in our
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bones, 27% in our muscles, 6-7% in other cells, and less than 1% extracellularly in the
serum (39,42,46,48,49). Serum Mg is found either bound to a protein (25% albumin, 8%
globulins), in a chelated fraction (meaning bound to a molecule, 12%), or in an ionized
state where it is metabolically available for physiological functions (55%) (12,46).
Magnesium is an important cofactor for more than 600 enzymes, meaning Mg is
required to be present and bound to the enzyme to catalyze the reaction (50,51).
Additionally, Mg is an activator for over 200 enzymatic reactions which is a type of
cofactor that enhances enzymatic activity (50,51). Without Mg, all of these enzymatic
reactions like energy production, protein synthesis, and insulin activation would not be
fulfilled (50).
The balance of Mg distribution and metabolism can be impacted by a variety of
hormones including the parathyroid hormone (PTH), antidiuretic hormone (ADH),
calcitonin, catecholamines, and insulin (12,20). Many impact Mg balance by controlling
level of Mg resorption in different parts of the kidneys (20,52–54). Parathyroid hormone
and Mg have a multifaceted relationship, as PTH will increase Mg resorption in the distal
convoluted tubule of the kidneys, while Mg may reduce secretion of parathyroid hormone
when calcium levels are low (20,52). When Mg levels are low, PTH will also stimulate
release of Mg from the bones and increase absorption in the small intestine (53).
Impaired PTH secretion and/or function can lead to hypomagnesemia which may induce
hypocalcemia, while elevated calcium levels can lead to decreased Mg resorption (52,54).
Antidiuretic hormone (or vasopressin) also has an effect on homeostasis of Mg (20).
Similarly to PTH, ADH will stimulate Mg resorption in the distal convoluted tubule (53).
Calcitonin regulates calcium in addition to Mg, by stimulating resorption in the thick
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ascending limb of the nephron loop (loop of Henle) of the kidney (53). Catecholamines
(like epinephrine, norepinephrine, and dopamine) can impact the intracellular balance of
ions, including Mg distribution (55). As catecholamines are released, extracellular fluid
increases resulting in a lower serum Mg (56). Insulin and Mg have a complex
relationship as they both impact each other. Insulin contributes to maintaining total body
Mg status, while Mg levels impact insulin activation and release from the beta cells of the
pancreas (12,14). Insulin can regulate Mg uptake, as it can reduce serum Mg causing
cytosolic levels of Mg to increase (57).
Dietary Sources, Requirements, and Intake
Magnesium is found in a variety of foods including green leafy vegetables,
legumes, nuts and seeds, whole grains, water (variable) and typically most high fiber and
high phytate foods (23,43,49). Even though Mg is present in a variety of foods available
in a Western diet, most adult Americans do not meet their daily requirements (49). Since
the early 1900s, Americans are now consuming half of the Mg of what they used to,
dropping from about 500mg/day to 250mg/day (49). This may be due in part to the
typical, overly processed American western diet which has decreased Mg content of food
by about 85% (49,58). Americans have increased processed food consumption, which can
therefore affect American’s dietary Mg intake (49).
For women of reproductive ages specifically, the recommended dietary allowance
(RDA) are 400mg/day, 350mg/day, and 360mg/day for ages 14-18, 18-30, and 31-50
years old, respectively (23). Magnesium needs increase during pregnancy by an
additional 40mg/day due to the increased body mass (39). Magnesium toxicity is rare,
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and has only occurred through consuming supplements with no reports of toxicity
exclusively through dietary intake (11).
The use of Mg dietary supplements can increase Mg intake. Magnesium
supplements are typically in the form of Mg oxide, citrate, stearate, acetyl taurate, or
chloride (43,58). Magnesium citrate and Mg oxide are most frequently prescribed when
dietary supplementation is necessary (58). A study performed on rats showed the highest
levels of blood Mg when being supplemented using Mg malate, suggesting Mg malate is
absorbed the most effectively, followed by Mg acetyl taurate suggesting these forms of
Mg are the most bioavailable (58). Prenatal vitamins are typically not a good source of
Mg intake, as only about 20% of prenatal supplements contain Mg (40). When Mg is in a
prenatal vitamin, on average contributes to 7.6% of the daily value required for
pregnancy (40). Therefore, if a woman is taking a prenatal vitamin, they would not be
able to meet their Mg needs with the prenatal vitamin alone. She would need to consume
food containing Mg or a Mg supplement to ensure adequate dietary intake. Previous
studies show the benefits of supplementing Mg to reduce the risk of chronic diseases like
T2DM, vitamin D deficiency, poor pregnancy outcomes (12,19,59).
Absorption
Only about 30-40% of dietary Mg intake is actually absorbed, but absorption can
range from 25% when consuming high amounts of Mg to 75% when consuming
inadequate amounts of Mg (20,46). Magnesium is absorbed as a free, unbound ion, Mg2+
and is absorbed best at a lower pH (47,60). It is absorbed passively primarily in the
jejunum and ileum of the small intestine, and less absorption occurs in the colon (12,20).
Absorption and retention of Mg is not affected by whether an individual has T2DM,
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however, gastrointestinal diseases such as celiac disease, inflammatory bowel syndrome,
and short bowel syndrome can have malabsorptive effects (12,47). Magnesium is
excreted through bile and urine, and resorption occurs in the kidneys (12,20,47).
The highly processed foods within the American western diet typically contain
phosphate additives (found in foods like processed meats and sugar sweetened beverages)
and low calcium intake, which can increase the required amount of Mg in order to remain
in a positive balance (49). On the other hand, excess amounts of calcium and vitamin D
can also increase Mg needs (49). Fiber, free fatty acids, oxalate, phytate, and high levels
of phosphorus, iron, copper, manganese, and zinc can inhibit Mg absorption as well
(47,61). However, many studies that investigated these relationships were using
physiologically improbable amounts of the minerals (47). Magnesium is found in many
foods containing phytates, and many believe that phytates found in foods will lower Mg
absorption and lead to Mg deficiency (49). However, resorption of Mg in the kidneys will
decrease the amount lost in the urine to make up for the Mg bound to the phytates being
excreted (49). Oxalic acid which is also found foods like spinach, cabbage, and brussels
sprouts, can also inhibit absorption of Mg by binding to it thus decreasing its ability to
absorb as a free ion (47). Aluminum consumption is another factor that can inhibit Mg
absorption thus increasing dietary needs, as aluminum is used in a variety of cookware,
packaging, and topical products (49).
Since Mg is typically consumed as a whole food complex and not as an isolated
form, many studies have researched the impact macronutrients and other food
components has on Mg absorption (47,62–66). A high protein has shown to improve Mg
absorption when compared to lower protein intake due to its effect on preventing Mg and
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calcium complexes from forming, which would decrease absorption (47,62–66). The type
of lipids consumed can also have an effect on Mg absorption in the gastrointestinal tract,
as medium chain triglycerides increase absorption compared to long chain triglycerides
(47). Additionally, low soluble and insoluble fibers can impact Mg absorption in the large
intestine (47,67). This is due to the fermentation that occurs in the colon which results in
a decreased, more acidic pH, thus improving Mg absorption (47,67). Lastly, it is possible
that lactose can enhance Mg absorption, as it has been shown in rats but there has been
conflicting evidence for the effect on humans (47,68).
Magnesium Regulation
Serum Mg can vary throughout the day due to our body’s regulatory mechanisms
(60). Our bones and muscles have a mechanism that releases Mg into the serum to remain
in homeostasis when Mg levels drop, therefore maintaining relatively constant serum Mg
status (12,39). Continuous reduced Mg intake leads to Mg depletion, causing the bone to
release Mg to maintaining Mg balance, which can negatively affect bone strength and
contribute to bone-related deficiencies and diseases (46).
In addition to bones, the kidneys also help to regulate serum Mg homeostasis via
renal resorption (20,46). About 96% of Mg is reabsorbed in the kidneys using active
transport, thus requiring energy (46,47). This resorption occurs in the nephron of the
kidney, and occurs to maintain balance of minerals (46). Ten to 30% of the Mg is
reabsorbed in the proximal convoluted tubule using a sodium gradient, 40-70%
reabsorbed in the thick ascending limb using cotransport and an electrochemical gradient,
and 5-10% through the distal convoluted tubule using active transport (46).
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Magnesium Status Measurements
The most common clinical diagnosis of hypomagnesemia uses serum Mg, but it is
a poor indication of Mg intake or total body status (20). Total body depletion of Mg can
be overlooked by a serum Mg reading, as serum Mg is a poor indicator of total body Mg
and dietary intake due to the body’s ability to regulate serum levels (20,46) Therefore,
hypomagnesemia is commonly undiagnosed (20). One reason may be attributed to the
homeostasis mechanisms of our bones and kidneys (12,20,39,46). Additionally, serum
Mg measurements include protein-bound Mg, and therefore changes in serum protein
concentrations may affect serum Mg measurements (20).
Magnesium status is also measured using ionized Mg, which may be a better
indicator for total body Mg than serum Mg (69). Ionized Mg represents the most
biologically available, unbound form of Mg and represents about 55% of Mg in the body
(35,69). Therefore, changes in proteins that may be bound to Mg will not affect ionized
Mg readings (20). However, the methodology of obtained ionized Mg still needs to be
researched to ensure accuracy, as it requires an ultrafilterable Mg and is not routinely
used (20,70). Obtaining ionized Mg is an invasive and complicated method to attain Mg
status, as it requires blood draw and further testing afterwards (20,70). There is no
documented method to accurately measure Mg status (70).
Measuring dietary intake using a food frequency questionnaire (FFQ) is the
preferred method to obtain Mg status (43). Diet*Calc software can be used to import the
nutrients into a Diet*Calc food database so they can then be analyzed (24). Diet*Calc can
be edited if a FFQ is modified (24).
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Magnesium and Diabetes
Due to its integral role in insulin activation and insulin release from the beta cells
of the pancreas, many studies show low Mg is strongly linked to development of T2DM
(13,14,71). A study by Mckeown et al.(13) reported high dietary and supplemental Mg
intake can reduce the risk of impaired glucose tolerance and metabolism in adults by
37%. Another study found that hypomagnesemia (total serum Mg below 1.7mg/dL) was
associated with T2DM due to its role with tyrosine kinase (TK) and activation of the
insulin receptor (71,72). Based on previous research that shows low serum Mg is
associated with T2DM onset, Pokharela et al. (71) evaluated the relationship between
hypomagnesemia and T2DM in a Nepalese population sample using a case-control
experimental design and found that hypomagnesemia was present in half of the
participants with diabetes (71). Furthermore, low serum Mg was associated with insulin
resistance and diabetes-related complications such as dyslipidemia, poor glycemic
control, and renal insufficiency (71). The research by Pokharela et al.(71) indicates that
low serum Mg is associated with insulin resistance, which creates the need to discuss the
physiologic relationship between Mg and insulin.
Magnesium affects insulin activity in two major ways: 1) insulin secretion from
the beta cells of the pancreas, and 2) activation of the insulin receptor (14,15). When Mg
levels are inadequate, it can inhibit the beta cells of the pancreas to release insulin
causing pancreatic beta cell dysfunction (14). Magnesium levels affect insulin secretion
in two ways, as there are two major steps involved in insulin secretion (14). First, Mg can
impact the phosphorylation by glucokinase after glucose entering the cell, as glucokinase
activity directly depends on a Mg-adenosine triphosphate (ATP) complex (14). Therefore
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when Mg levels are low, the cell cannot successfully entrap glucose by phosphorylation
(14). In a normal healthy adult, the beta cells use changes in membrane potential to react
to glucose in the blood and secrete insulin (14). This membrane potential can become
disrupted when a potassium channel becomes blocked causing membrane depolarization
(14). Magnesium’s role in this second step is to activate and open the potassium channel
which will stimulate the release of insulin (14).
The second major way Mg can impact insulin is through insulin receptor
activation (48). Insulin activation begins with binding of insulin to the alpha subunit of its
TK insulin receptor resulting in phosphorylation of the TK subunit (14). Magnesium is
the main cofactor for the phosphorylating TK (69). More specifically, free intracellular
Mg will bind to the phosphate groups on ATP to form a Mg-ATP complex (12,51). When
Mg is attached to ATP, it improves the binding ability of ATP to active sites of protein
kinases including TK (51,69,73). Once TK is phosphorylated and activated, it can
subsequently initiate the effects of insulin activity, creating a cascade of reactions to
bring glucose into cells for use or storage (13,72,74). Gestational diabetes is typically
attributed to a combination of pancreatic beta-cell dysfunction and insulin resistance
which can be caused by reduced TK phosphorylation (4). Therefore, when there is low
intracellular Mg, TK cannot auto-phosphorylate as efficiently which results in disordered
TK activity, thus insulin resistance (69).
A study done by Tasdemir, et al.(35) compared the ionized unbound Mg and total
body Mg levels in women with and without GDM using in 85 pregnant women, of which
40 of were diagnosed with GDM. Tasdemir, et al.(35) hypothesized low Mg would be
associated with insulin resistance during pregnancy based on previous research showing
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an association between hypomagnesemia and impaired glucose. The results showed a
relationship between low total Mg and low ionized Mg and development of GDM, thus
suggesting Mg is a crucial ion in the development of GDM (35). Given that the
pathophysiologic mechanism for both T2DM and GDM are the same in that both observe
insulin resistance, it is critical to investigate how supplemental and dietary intake of Mg
may be associated with GDM (10).
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Chapter 2: Gestational Diabetes
Background, Prevalence, and Cost of GDM
Gestational diabetes is defined as glucose intolerance that is first recognized while
pregnant, and is typically diagnosed between 24-28 weeks gestation without any prior
diagnosis of type 1 or T2DM (4,7,75). Glucose intolerance is defined as a fasting blood
glucose of >126 mg/dL or a 2 hour post prandial 75g oral glucose tolerance test (OGTT)
value of over 200 mg/dL (2,7). Historically, GDM diagnosis was not always
standardized, and therefore many cases may have gone undiagnosed (4). Undiagnosed
and therefore untreated GDM can have continuous risks of morbidity and mortality for
the mother and the baby (76). Screening, diagnosing, and treating cases of GDM is
important for maternal and fetal health outcomes during and after pregnancy, as well as
healthcare spending (6,77).
Gestational diabetes is also quite costly. In the US in 2007, GDM-related
diagnoses cost an additional $3,305 per pregnancy, totaling $636 million in increased
healthcare dollars (6). About 50% of GDM typically subsides postpartum, which means
50% continues on to T2DM contributing to the $327 billion spent on T2DM in 2017
(2,4,5,78). Gestational diabetes was estimated affect 1-14% (1 in 7) of pregnancies
globally in 2017 (10,79) and represented 83-87.5% of all diabetic pregnancies globally
(75). This prevalence marks GDM the most common condition women develop during
pregnancy and diagnoses continue to increase worldwide (2,3). The suspected increase in
GDM development may be due to the rise in obesity, reduction in physical activity, and
increase in maternal age (10). It is recommended to complete screenings earlier in
pregnancy (meaning at the beginning of the first trimester and/or when antenatal care
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begins) for women who may have these risk factors so that non-GDM diabetes can be
diagnosed if present, and therefore GDM is not being mistaken for pre-existing diabetes
(10). To date, there is still no standard method of diagnosing GDM during an early
pregnancy screening and it is still controversial, as physicians may use fasting plasma
glucose, random plasma glucose, HbA1C, or 75g 2 hour OGTT (10). Gestational diabetes
is typically diagnosed in a screening later in pregnancy during the third trimester (10).
Risk Factors & Adverse Outcomes of GDM
There are many factors that may increase the risk of developing GDM. Common
risks include pre-pregnancy overweight or obesity, gestational weight gain, central
adiposity, hypertension or preeclampsia during pregnancy, western diet patterns,
micronutrient deficiencies (e.g. vitamins B2, B6, B12, and folic acid which are vital in
homocysteine homeostasis), maternal age >35 years old, and family history of diabetes
(4,25,80). The risk of developing GDM increases as BMI increases, where a study
showed it was 2.14 times higher in pregnant women who are overweight (BMI 25.029.9kg/m2), 3.56 times higher in pregnant women who are obese (BMI 30.0-34.9kg/m2),
and 8.56 times higher in very obese pregnant women (BMI >35.0kg/m2) when compared
to pregnant women with a normal BMI (BMI 18.5-24.9kg/m2) (81).
Gestational diabetes can lead to adverse maternal and fetal outcomes and has been
studied extensively. The Hyperglycemic and Adverse Pregnancy (HAPO) Study looked
at adverse pregnancy outcomes in pregnant women with obesity and GDM (82). This
research showed that GDM and obesity are both independently associated with adverse
pregnancy and birth outcomes, but together have an even stronger association with each
outcome analyzed (82). Catalano et al.(82) used an OGTT to diagnose GDM which
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showed women with GDM had a higher prevalence of higher birthweight, newborn body
fat percent, c-section, and preeclampsia than women without GDM (82). An increase in
fetal adiposity can develop with maternal hyperglycemia which can be a contributing risk
factor for chronic diseases like cardiovascular disease and T2DM for the offspring later
in life (82,83). Other common fetal consequences from maternal GDM that are increased
when GDM is not recognized are macrosomia, large for gestational age, shoulder
dystocia, and other kinds of birth trauma (76,84). A prospective 4-year cohort study by
Yang et al.(3) found GDM prevalence was associated with high birth weight, as well as
an increased risk for large for gestational age and macrosomia. Fetal macrosomia occurs
in about 15-45% of babies born to mothers with diabetes which is 3 times more than
mothers with normal blood glucose levels (85,86). This is due to a modification in lipid
metabolism from maternal hyperinsulinemia which can occur as a response to
hyperglycemia, resulting in increased protein and fat storage of the fetus (3,85,86).
Hyperinsulinemia occurs when the beta cells of the pancreas overproduce insulin in
response to continued elevated blood glucose levels from resistant insulin (87). A study
by Ogonowski et al.(85) showed the rate of macrosomia and large for gestational age is
decreased when maternal hyperglycemia is treated and controlled. This supports the need
to screen for GDM so it can be properly treated to avoid adverse fetal outcomes (85).
Development of GDM can also lead to unfavorable maternal short and long term
outcomes (75,88). The most common potential risks of developing GDM for mothers
include c-section delivery, pre-eclampsia or pregnancy-induced hypertension, weight
gain, increased triacylglycerol blood concentrations, decreased high-density lipoproteins,
decreased insulin sensitivity post-partum and/or development of T2DM (60% of women
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with GDM develop T2DM later in life), antenatal depression, and increased maternal
adipose tissue (75,88–90). These studies, among many others (3,4,10,79), indicate that
GDM can lead to unfavorable birth outcomes and development of chronic diseases for
the mother and child, thus providing a strong foundation as to why it is important to
examine strategies to decrease GDM prevalence.
Mechanism of Insulin in GDM
Insulin is made in the beta cells of the pancreas. When blood glucose levels are
elevated, insulin is released in response to a change in membrane potential (10,14,87).
Insulin acts by signaling the insulin-dependent GLUT transporter proteins by binding to
their membrane receptors on the apical membrane of cells when glucose is elevated to
transport glucose out of the blood and into the cell (45).The mechanism of GDM is
similar to T2DM, where the beta cells do not release insulin in response to the elevated
glucose levels, or the insulin that is released is is impaired and does not stimulate the
GLUT transporter proteins in reaction to the stimulation of elevated blood glucose levels,
and therefore does not facilitate glucose uptake into cells (87,88). Specifically, the
translocation of GLUT4 that is normally stimulated by insulin to increase glucose uptake
is impaired (7). This can lead to hyperglycemia, potentially hyperinsulinemia, as insulin
initiates uptake of glucose by cells in the fed state (45). Gestational diabetes can occur
when a mother is hyperglycemic due to these pathophysiological mechanisms of insulin
(88).

33

APPENDIX B: BIBLIOGRAPHY
1.

Zhou T, Sun D, Li X, Heianza Y, Nisa H, Hu G, et al. Prevalence and Trends in
Gestational Diabetes Mellitus among Women in the United States, 2006–2016.
Am Diabetes Assoc. 2018;67(1).

2.

Hunt KJ, Schuller KL. The increasing prevalence of diabetes in pregnancy. Obs
Gynecol Clin North Am [Internet]. 2008;34(2):173–vii. Available from:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2043158/pdf/nihms26882.pdf

3.

Yang Y, Wang Z, Mo M, Muyiduli X, Wang S, Li M, et al. The association of
gestational diabetes mellitus with fetal birth weight. J Diabetes Complications
[Internet]. 2018 Jul 1 [cited 2019 Jan 24];32(7):635–42. Available from:
https://www.sciencedirect.com/science/article/pii/S1056872717315544

4.

Plows JF, Stanley JL, Baker PN, Reynolds CM, Vickers MH. The
Pathophysiology of Gestational Diabetes Mellitus. Int J Mol Sci. 2018;19:1–21.
Centers for Disease Control and Prevention. Gestational Diabetes [Internet]. 2019
[cited 2019 Aug 8]. Available from:
https://www.cdc.gov/diabetes/basics/gestational.html

5.

6.

Chen Y, Quick WW, Yang W, Zhang Y, Baldwin A, Moran J, et al. Cost of
gestational diabetes mellitus in the united states in 2007. Popul Health Manag.
2009;12(3):165–71.

7.

Barbour LA, McCurdy CE, Hernandez TL, Kirwan JP, Catalano PM FJ. Cellular
Mechanisms for Insulin Resistance in Normal Pregnancy and Gestational Diabetes.
Diabetes Care. 2007;30(2):S112–S119.

8.

Association AD. Diagnosing Diabetes and Learning About Prediabetes [Internet].
American Diabetes Association. 2019. Available from:
http://www.diabetes.org/diabetes-basics/diagnosis/

9.

Edwards KL. Type 2 Diabetes. Gene-Environment Interact Fundam Ecogenetics.
2006;285–301.

10.

Johns EC, Denison FC, Norman JE, Reynolds RM. Gestational Diabetes Mellitus:
Mechanisms, Treatment, and Complications. Trends Endocrinol Metab [Internet].
2018 [cited 2019 Apr 23];29(11):743–54. Available from:
https://doi.org/10.1016/j.tem.2018.09.004

11.

Higdon J, Drake V, Delage B, Volpe S. Magnesium | Linus Pauling Institute |
Oregon State University [Internet]. Linus Pauling Institute. 2019 [cited 2019 Jan
24]. Available from: https://lpi.oregonstate.edu/mic/minerals/magnesium

34

12.

Barbagallo M, Dominguez LJ. Magnesium and type 2 diabetes. World J Diabetes
[Internet]. 2015 Aug 25 [cited 2019 Jan 24];6(10):1152–7. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/26322160

13.

Mckeown NM, Hruby A, Meigs JB, O’donnell CJ, Jacques PF. Higher Magnesium
Intake Reduces Risk of Impaired Glucose and Insulin Metabolism and Progression
From Prediabetes to Diabetes in Middle-Aged Americans. Diabetes Care
[Internet]. 2014 [cited 2019 Apr 22];37:419–27. Available from:
http://care.diabetesjournals.org/lookup/suppl/doi:10.2337/dc13-1397/-/DC1.

14.

Kostov K. Effects of magnesium deficiency on mechanisms of insulin resistance in
type 2 diabetes: Focusing on the processes of insulin secretion and signaling. Int J
Mol Sci. 2019;20(6).

15.

Asemi Z, Karamali M, Jamilian M, Foroozanfard F, Bahmani F, Heidarzadeh Z, et
al. Magnesium supplementation affects metabolic status and pregnancy outcomes
in gestational diabetes: a randomized, double-blind, placebo-controlled trial 1. Am
J Clin Nutr [Internet]. 2015 [cited 2019 Apr 22];102(1):222–9. Available from:
https://academic.oup.com/ajcn/article-abstract/102/1/222/4564250

16.

Akizawa Y, Koizumi S, Itokawa Y, Ojima T, Nakamura Y, Tamura T, et al. Daily
magnesium intake and serum magnesium concentration among Japanese people. J
Epidemiol. 2008;18(4):151–9.

17.

Zhang X, Xia J, Gobbo LC Del, Hruby A, Dai Q, Song Y. Serum magnesium
concentrations and all-cause, cardiovascular, and cancer mortality among U.S.
adults: Results from the NHANES I Epidemiologic Follow-up Study *. 2018 [cited
2019 Mar 19];37:1541–9. Available from:
http://dx.doi.org/10.1016/j.clnu.2017.08.021

18.

Dinicolantonio JJ, O’keefe JH, Wilson W. Subclinical magnesium deficiency: a
principal driver of cardiovascular disease and a public health crisis Coronary artery
disease. Open Hear [Internet]. 2018 [cited 2019 Mar 19];5:668. Available from:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5786912/pdf/openhrt-2017000668.pdf

19.

Zarean E, Tarjan A. Effect of Magnesium Supplement on Pregnancy Outcomes: A
Randomized Control Trial. Adv Biomed Res. 2017;6(1):109.

20.

Seo JW, Park TJ. Magnesium Metabolism. Electrolyte Blood Press [Internet].
2008 [cited 2019 Apr 22];6:86–95. Available from:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3894481/pdf/ebp-6-86.pdf

21.

Breastfeeding and Infant Feeding Practices [Internet]. Centers for Disease Control
and Prevention. 2017 [cited 2019 Apr 30]. Available from:
https://www.cdc.gov/breastfeeding/data/ifps/questionnaires.htm

35

22.

Fein SB, Labiner-Wolfe J, Shealy KR, Li R, Chen J, Grummer-Strawn LM. Infant
Feeding Practices Study II: Study Methods. Pediatrics. 2008;122(Supplement
2):S28–35.

23.

Novkovic M. Institute of Medicine (US) Standing Committee on the Scientific
Evaluation of Dietary Reference Intakes. Dietary reference intakes for calcium,
phosphorus, magnesium, vitamin D, and fluoride. National Academies Press (US),
[Internet]. Bosnia-Herzegovina. 1997. 661 p. Available from:
http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&
D=psyc3&AN=2004-16447019%5Cnhttp://vq2st5lq8v.search.serialssolutions.com?url_ver=Z39.882004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rfr_id=info:sid/Ovid:psyc3&rft.g
enre=article&rft_id=

24.

National Cancer Institute. Dietary History Questionnaire (Archive Version)
[Internet]. Epidemiology and Genomics Research Program. 2001. Available from:
https://epi.grants.cancer.gov/DHQ/

25.

Alfadhli EM. Gestational diabetes mellitus. Saudi Med J [Internet]. 2015 [cited
2019 Apr 30];36(4):399–406. Available from: www.smj.org.sa

26.

Ford ES, Mokdad AH. Nutritional Epidemiology — Research Communication
Dietary Magnesium Intake in a. J Nutr. 2003;133(9):2879–82.

27.

Looman M, Schoenaker DAJM, Soedamah-Muthu SS, Mishra GD, Geelen A,
Feskens EJM. Pre-pregnancy dietary micronutrient adequacy is associated with
lower risk of developing gestational diabetes in Australian women ScienceDirect.
Nutr Res [Internet]. 2019 [cited 2019 Jan 30];62:32–40. Available from:
https://doi.org/10.1016/j.nutres.2018.11.006

28.

Wanga N, Dinga Y, Wu J. Effects of pre-pregnancy body mass index and
gestational weight gain on T neonatal birth weight in women with gestational
diabetes mellitus. Early Hum Dev [Internet]. 2018;124:17–21. Available from:
https://pdf.sciencedirectassets.com/271277/1-s2.0-S0378378218X00085/1-s2.0S0378378217306291/main.pdf?x-amz-securitytoken=AgoJb3JpZ2luX2VjEMb%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwE
aCXVzLWVhc3QtMSJIMEYCIQCF2yfyTCiqxWWHCEB%2BHZh1ptHSKPPH
M%2FXNmE0O5EaeVQIhAKiuXzIM

29.

Huang JH, Lu YF, Cheng FC, Lee JNY, Tsai LC. Correlation of magnesium intake
with metabolic parameters, depression and physical activity in elderly type 2
diabetes patients: A cross-sectional study. Nutr J. 2012;11(1):1–10.

36

30.

Nabouli MR, Lassoued L, Bakri Z, Moghannem M. Modification of Total
Magnesium level in pregnant Saudi Women developing gestational diabetes
mellitus. Diabetes Metab Syndr Clin Res Rev [Internet]. 2016 [cited 2019 Jan
30];10:183–5. Available from: http://dx.doi.org/10.1016/j.dsx.2016.06.001

31.

National Institute of Health. U.S. National Library of Medicine [Internet]. 2016.
Available from:
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=42a5cafd-a2c0-4ac299c9-708642f00716

32.

Shin D, Lee K, Song W, Shin D, Lee KW, Song WO. Dietary Patterns during
Pregnancy Are Associated with Risk of Gestational Diabetes Mellitus. Nutrients
[Internet]. 2015 Nov 12 [cited 2019 Jan 29];7(11):9369–82. Available from:
http://www.mdpi.com/2072-6643/7/11/5472

33.

Olivier J, Bell ML. Effect Sizes for 2×2 Contingency Tables. PLoS One.
2013;8(3):1–7.

34.

Erdfelder E, FAul F, Buchner A, Lang AG. Statistical power analyses using
G*Power 3.1: Tests for correlation and regression analyses. Behav Res Methods.
2009;41(4):1149–60.

35.

Tasdemir G, Tasmedir N, Kilic S, Abali R, Celik C, Gulerman H. Alterations of
ionized and total magnesium levels in pregnant women with gestational diabetes
mellitus. Gynecol Obs Investig [Internet]. 2014;79(1):19–24. Available from:
https://www-ncbi-nlm-nihgov.uri.idm.oclc.org/pubmed/?term=Alterations+of+ionized+and+total+magnesiu
m+levels+in+pregnant+women+with+gestational+diabetes+mellitus.

36.

Zarean E, Tarjan A. Effect of Magnesium Supplement on Pregnancy Outcomes: A
Randomized Control Trial. Adv Biomed Res [Internet]. 2017 [cited 2019 May
15];6(1):109. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28904937

37.

Lawrence RL, Wall CR, Bloomfield FH. Prevalence of gestational diabetes
according to commonly used data sources: An observational study. BMC
Pregnancy Childbirth. 2019;19(1):1–9.

38.

Kozlowska A, Jagielska AM, Okreglicka KM, Dabrowski F, Kanecki K, NitschOsuch A, et al. Dietary vitamin and mineral intakes in a sample of pregnant
women with either gestational diabetes or type 1 diabetes mellitus, assessed in
comparison with Polish nutritional guidelines. Ginekol Pol [Internet]. 2018 Nov 30
[cited 2019 Jan 31];89(11):581–6. Available from:
https://journals.viamedica.pl/ginekologia_polska/article/view/59364

37

39.

Dalton LM, N I Fhloinn DM, Gaydadzhieva GT, Mazurkiewicz OM, Leeson H,
Wright CP. Magnesium in pregnancy. Nutr Rev [Internet]. 2016 [cited 2019 Jan
31];74(9):549–57. Available from:
https://academic.oup.com/nutritionreviews/article-abstract/74/9/549/1752003

40.

U.S. National Library of Medicine. Daily Med [Internet]. [cited 2018 Sep 19].
Available from:
https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=prenatal

41.

Shim J-S, Oh K, Kim HC. Dietary assessment methods in epidemiologic studies.
Epidemiol Health. 2014;e2014009.

42.

Vormann J. Magnesium: nutrition and metabolism. Mol Aspects Med [Internet].
2003 [cited 2019 Apr 18];24:27–37. Available from:
www.elsevier.com/locate/mam

43.

National Institute of Health. Magnesium: Fact Sheet for Health Professionals
[Internet]. 2018 [cited 2018 Oct 20]. Available from:
https://ods.od.nih.gov/factsheets/Magnesium-HealthProfessional/

44.

Institute of Medicine (US) Food and Nutrition Board. Concepts Underlying the
Recommended Dietary Allowances. 1994; Available from:
https://www.ncbi.nlm.nih.gov/books/NBK231420/

45.

Stipanuk MH, Caudill MA. In Reply: BEHAVIOUR THERAPY. Vol. 112, The
British Journal of Psychiatry. 1966. 211–212 p.

46.

Blaine J, Chonchol M, Levi M. Renal control of calcium, phosphate, and
magnesium homeostasis. Clin J Am Soc Nephrol. 2015;10(7):1257–72.

47.

Schuchardt JP, Hahn A. Intestinal Absorption and Factors Influencing
Bioavailability of Magnesium- An Update. Curr Nutr Food Sci. 2017;13(4):260–
78.

48.

Jahnen-Dechent W, Ketteler M. Magnesium basics. Clin Kidney J [Internet]. 2012
[cited 2019 May 30];(5):3–14. Available from:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4455825/pdf/sfr163.pdf

49.

Dinicolantonio JJ, O’keefe JH, Wilson W. Subclinical magnesium deficiency: a
principal driver of cardiovascular disease and a public health crisis Coronary artery
disease. Open Hear [Internet]. 2018 [cited 2019 Feb 24];5:668. Available from:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5786912/pdf/openhrt-2017000668.pdf

50.

de Baaij JHF, Hoenderop JGJ, Bindels RJM. Magnesium in man: Implications for
health and disease. Physiol Rev. 2015;95(1):1–46.

38

51.

Gropper S, Smith J, Carr T. Advanced Nutrition and Human Metabolism. 7th ed.
Boston, MA: Cengage Learning; 2018.

52.

Rodríguez-Ortiz ME, Canalejo A, Herencia C, Martínez-Moreno JM, PeraltaRamírez A, Perez-Martinez P, et al. Magnesium modulates parathyroid hormone
secretion and upregulates parathyroid receptor expression at moderately low
calcium concentration. Nephrol Dial Transplant. 2014;29(2):282–9.

53.

Saris NEL, Mervaala E, Karppanen H, Khawaja JA, Lewenstam A. Magnesium:
An update on physiological, clinical and analytical aspects. Clin Chim Acta.
2000;294(1–2):1–26.

54.

Vormann J. Magnesium : Nutrition and Homoeostasis. AIMS Public Heal.
2016;3(November 2015):329–40.

55.

Swaminathan R. Magnesium Metabolism and its Disorders. Clin Biochem Rev
[Internet]. 2003;24(2):47–66. Available from:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1855626/

56.

Tso EL, Barish RA. Magnesium: Clinical considerations. J Emerg Med.
1992;10(6):735–45.

57.

Gommers LMM, Hoenderop JGJ, Bindels RJM, De Baaij JHF. Hypomagnesemia
in type 2 diabetes: A vicious circle? Diabetes. 2016;65(1):3–13.

58.

Uysal N, Kizildag S, Yuce Z, Guvendi G, Kandis S, Koc B, et al. Timeline
(Bioavailability) of Magnesium Compounds in Hours: Which Magnesium
Compound Works Best? Biol Trace Elem Res. 2019;187(1):128–36.

59.

Deng X, Song Y, Manson JE, Signorello LB, Zhang SM, Shrubsole MJ, et al.
Magnesium, vitamin D status and mortality: results from US National Health and
Nutrition Examination Survey (NHANES) 2001 to 2006 and NHANES III. BMC
Med [Internet]. 2013 [cited 2019 Mar 26];11(187):1–14. Available from:
http://www.biomedcentral.com/1741-7015/11/187

60.

Workinger JL, Doyle RP, Bortz J. Challenges in the diagnosis of magnesium
status. Nutrients. 2018;10(9).

61.

Costello RB, Nielsen F. Interpreting Magnesium Status to Enhance Clinical CareKey Indicators. Curr Opin Clin Nutr Metabl Care [Internet]. 2017 [cited 2019 Feb
24];20(6):504–11. Available from:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5812344/pdf/nihms939616.pdf

62.

Lakshmanan FL, Rao RB, Church JP. Calcium and phosphorus intakes, balances,
and blood levels of adults consuming self-selected diets. Am J Clin Nutr.
1984;40(6 SUPPL.):1368–79.

39

63.

Schwartz R, Walker G, Linz MD, MacKellar I. Metabolic responses of adolescent
boys to two levels of dietary magnesium and protein. I. Magnesium and nitrogen
retention. Am J Clin Nutr. 1973;26(5):510–8.

64.

McCance RA, Widdowson EM, Lehmann H. the Effect of Protein Intake on the
Absorption of Calcium and Magnesium. Br Med Bull. 1943;1(6):65–65.

65.

Allen L, Berkowitz G, Dallman P, Hambidge KM, Kriskey A, Niebly JR, et al.
Calcium, Vitamin D, and Magnesium. In: Nutrition During Pregnancy: Part I:
Weight Gain, Part II: Nutrient Supplements [Internet]. Washington D.C.: National
Academy of Sciences; 1990 [cited 2019 May 15]. p. 318–35. Available from:
http://www.nap.edu.

66.

Hunt S, Schofield F. Magnesium Level Balance in Adult Human Protein Female.
Am J Clin Nutr. 1969;22(3):367–73.

67.

Younes H, Demigné C, Rémésy C. Acidic fermentation in the caecum increases
absorption of calcium and magnesium in the large intestine of the rat. Br J Nutr.
1996;75(2):301–14.

68.

Heijnen AMP, Brink EJ, Lemmens AG, Beynen AC. Ileal pH and apparent
absorption of magnesium in rats fed on diets containing either lactose or lactulose.
Br J Nutr. 1993;70(3):747–56.

69.

Barbagallo M, Dominguez LJ. Magnesium metabolism in type 2 diabetes mellitus,
metabolic syndrome and insulin resistance. Arch Biochem Biophys [Internet].
2007 [cited 2019 Mar 21];458:40–7. Available from:
www.elsevier.com/locate/yabbi

70.

Arnaud MJ. Update on the assessment of magnesium status British Journal of
Nutrition. Br J Nutr. 2008;99(3):24–36.

71.

Pokharela DR, Khadkac D, Sigdela M, Yadava NK, Kafleb R, Sapkotad RM, et al.
Association of serum magnesium level with poor glycemic control and renal
functions in Nepalese patients with type 2 diabetes mellitus. Diabetes Metab Syndr
Clin Res Rev [Internet]. 2017;11S:S417–23. Available from: https://ac-els-cdncom.uri.idm.oclc.org/S1871402117300140/1-s2.0-S1871402117300140main.pdf?_tid=b1652945-2f9f-4906-a15c8f8bd6a86514&acdnat=1551320617_cb230c5e0eeb1fb34ec2202f766d5004

72.

Wente SR, Villalba M, Schramm VL, Rosen OM. Mn2(+)-binding properties of a
recombinant protein-tyrosine kinase derived from the human insulin receptor. Proc
Natl Acad Sci U S A [Internet]. 1990 Apr [cited 2019 Feb 20];87(7):2805–9.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/2157215

40

73.

Yu L, Xu L, Xu M, Wan B, Yu L, Huang Q. Role of Mg2+ ions in protein kinase
phosphorylation: Insights from molecular dynamics simulations of ATP-kinase
complexes. Mol Simul. 2011;37(14):1143–50.

74.

Viñals F, Camps M, Testar X, Palacín M, Zorzano A. Effect of cations on the
tyrosine kinase activity of the insulin receptor: Inhibition by fluoride is magnesium
dependent [Internet]. Vol. 171, Molecular and Cellular Biochemistry. 1997 [cited
2019 May 29]. Available from: https://link-springercom.uri.idm.oclc.org/content/pdf/10.1023%2FA%3A1006836001489.pdf

75.

Stewart ZA, Murphy HR. Gestational diabetes. Medicine (Baltimore) [Internet].
2015 [cited 2019 Apr 23];43:44–7. Available from:
https://pdf.sciencedirectassets.com/273575/1-s2.0-S1357303914X00137/1-s2.0S1357303914003004/main.pdf?x-amz-securitytoken=AgoJb3JpZ2luX2VjEOv%252F%252F%252F%252F%252F%252F%252F
%252F%252F%252FwEaCXVzLWVhc3QtMSJGMEQCIF%252Fp%252FMFit9
9P6jSMtMfpdga82MR%252B

76.

Langer O, Yogev Y, Most O, Xenakis EMJ. Gestational diabetes: The
consequences of not treating. Am J Obstet Gynecol. 2005;192(4):989–97.

77.

Ranni PR, Begum J. Screening and Diagnosis of Gestational Diabetes Mellitus,
Where Do We Stand. J Clin Diagnostic Res. 2016;10(4):1–4.

78.

American Diabetes Association [Internet]. 2016. Available from:
http://www.diabetes.org/diabetes-basics/diagnosis/

79.

Stark Casagrande S, Linder B, Cowie CC. Prevalence of gestational diabetes and
subsequent Type 2 diabetes among U.S. women. Diabetes Res Clin Pract
[Internet]. 2018 [cited 2019 Apr 6];141:200–8. Available from:
https://doi.org/10.1016/j.diabres.2018.05.010

80.

Pons RS, Rockett FC, de Almeida Rubin B, Oppermann MLR, Bosa VL. Risk
factors for gestational diabetes mellitus in a sample of pregnant women diagnosed
with the disease. Diabetol Metab Syndr [Internet]. 2015;7(S1):A80. Available
from: http://www.dmsjournal.com/content/7/S1/A80

81.

Chu SY, Callaghan WM, Kim SY, Schmid CH, Lau J, England LJ, et al. Maternal
obesity and risk of gestational diabetes mellitus. Diabetes Care. 2007;30(8):2070–
6.

41

82.

Catalano PM, McIntyre HD, Cruickshank JK, McCance DR, Dyer AR. The
Hyperglycemia and Adverse Pregnancy Outcome Study: Associations of GDM
and obesity with pregnancy outcomes. Diabetes Care [Internet]. 2012;35(4):780–6.
Available from: https://search-proquestcom.uri.idm.oclc.org/docview/963517850/fulltext/D7835BDFF9134231PQ/1?acco
untid=28991

83.

Logan KM, Gale C, Hyde MJ, Santhakumaran S, Modi N. Diabetes in pregnancy
and infant adiposity: Systematic review and meta-analysis. Arch Dis Child Fetal
Neonatal Ed. 2017;102(1):F65–72.

84.

Adams KM, Li H, Nelson RL, Ogburn J, Danilenko-Dixon DR, Sunkel DR, et al.
Sequelae of unrecognized gestational diabetes. Am J Obstet Gynecol.
1998;178(6):1321–32.

85.

Ogonowski J, Miazgowski T, Czeszynska MB, Jaskot B, Kuczynska M, Celewicz
Z. Factors influencing risk of macrosomia in women with gestational diabetes
mellitus undergoing intensive diabetic care. Diabetes Res Clin Pract [Internet].
2008;80(3):405–10. Available from:
https://www.sciencedirect.com/science/article/pii/S0168822708000466

86.

Kc K, Shakya S, Zhang H. Gestational diabetes mellitus and macrosomia: A
literature review. Ann Nutr Metab. 2015;66:14–20.

87.

Wilcox G. Insulin and insulin resistance. Clin Biochem Rev. 2005;26(2):19–39.

88.

Catalano PM, Kirwan JP, Haugel-de Mouzon S, King J. Gestational Diabetes and
Insulin Resistance: Role in Short- and Long-Term Implications for Mother and
Fetus. J Nutr. 2003;133(5):1674S-1683S.

89.

Byrn M, Penckofer S. The Relationship Between Gestational Diabetes and
Antenatal Depression. JOGNN - J Obstet Gynecol Neonatal Nurs [Internet].
2015;44(2):246–55. Available from: http://dx.doi.org/10.1111/1552-6909.12554

90.

Peters RK, Kjos SL, Xiang A, Buchahan TA. Long-term diabetogenic effect of
single pregnancy in women with previous gestational diabetes mellitus. Lancet.
1996;347(8996):227–30.

42

